Pregled bibliografske jedinice broj: 671917
Fertility preservation with ovarian stimulation protocols prior to cancer treatment
Fertility preservation with ovarian stimulation protocols prior to cancer treatment // Gynecological endocrinology, 30 (2014), 3; 182-186 doi:10.3109/09513590.2013.860123 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 671917 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Fertility preservation with ovarian stimulation protocols prior to cancer treatment
Autori
Kasum, Miro ; Šimunić, Velimir ; Orešković, Slavko ; Beketić-Orešković, Lidija
Izvornik
Gynecological endocrinology (0951-3590) 30
(2014), 3;
182-186
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
fertility preservation; cancer treatment
Sažetak
An increasing trend towards later childbearing has been reported recently in many developed countries. Although the incidence of reproductive age in women who have delayed pregnancy with cancer is 10%, they may be concerned regarding the preservation of ovarian function due to advanced fertile age and with the impact of cancer treatment on later fertility. Among multiple strategies controlled, ovarian stimulation for embryo or oocyte cryopreservation is currently the most established method for fertility preservation. It is important to choose the appropriate ovulation induction protocol prior to oncologic treatment, because most of these patients have only the chance of a single cycle to conceive. Current treatment protocols offer a minimal time delay until oncologic treatment is commenced. In urgent settings, random-start ovarian stimulation represents a new technique which provides a significant advantage by decreasing the total time of the treatment, because it may be started irrespective of the phase of the cycle without compromising oocyte yield and maturity before cancer treatment. However, in patients with oestrogen-sensitive cancers stimulation, protocols using letrozole are currently preferred over tamoxifen regimens, and therefore, it may be highly advisable to use letrozole with gonadotrophins routinely as a safe, effective and novel protocol of ovulation induction.
Izvorni jezik
Engleski
POVEZANOST RADA
Projekti:
074-0982464-1187 - KLINIČKO ZNAČENJE TUMORSKE HIPOKSIJE U BOLESNIKA LIJEČENIH RADIOTERAPIJOM (Beketić-Orešković, Lidija, MZOS ) ( CroRIS)
14305
108-1080399-0383 - Muški i ženski spolni sustav: razvoj, normalna histofiziologija i neplodnost (Ježek, Davor, MZOS ) ( CroRIS)
Ustanove:
Klinika za tumore,
Medicinski fakultet, Zagreb,
KBC "Sestre Milosrdnice",
Klinički bolnički centar Zagreb
Profili:
Slavko Orešković
(autor)
Velimir Šimunić
(autor)
Miro Kasum
(autor)
Lidija Beketić-Orešković
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE